Fundraising FoxBioMotiv
Cleveland, US · Delaware LLC
Find your way into BioMotiv
Sign up to find every way you can get introduced to BioMotiv
- Your email: who you already know at BioMotiv, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BioMotiv team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
BS
Baiju ShahChief Executive Officer and Board of Managers
TT
Ted Torphy, Ph.D.Chief Scientific Officer
CM
Charles McOsker, Ph.D.Vice President, Technical Operations
TV
Terry VanceChief Business Officer
SS
Stacie SwitzerSenior Vice President and General Counsel
Board
RS
Robert S. ReitmanBoard of Managers
CB
Carmen Bozic, M.D.Board of Managers
RG
Ronald G. HarringtonBoard of Managers
DC
David C. U'Prichard, Ph.D.Board of Managers and Chair of Advisory Board
JS
Jonathan S. Stamler, M.D.Board of Managers
GM
Graeme Martin, Ph.D.Board of Managers
Reported raises · per SEC filings
Form D private placements$290.4M disclosed across 2 rounds · 2012
▶$145.7MraisedAug 2018 · 62 investors · BiotechnologyRule 506(b)
▶$145.7MraisedAug 2018 · 62 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mark TeagueExecutive Officer
- Jeffrey Edelson, MDExecutive Officer
- Carmen Bozic, MDDirector
- Stacie SwitzerExecutive Officer
- Baiju R. ShahExecutive Officer, Director
- Terry VanceExecutive Officer
- Robert S. ReitmanDirector
- David C. U'Prichard, Ph.D.Director
- Charles McOsker, Ph.D.Executive Officer
- Ronald G. HarringtonDirector
- Jonathan S. Stamler, M.D.Director
- Michael Martin, Ph.D.Director
- Theodore Torphy, Ph.D.Executive Officer
- Offering amount
- $200M
- Amount sold
- $145.7M
- First sale
- Aug 2012
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$144.7MraisedAug 2016 · 62 investors · BiotechnologyRule 506(b)
▶$144.7MraisedAug 2016 · 62 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Baiju ShahExecutive Officer, Director
- Ted Torphy, Ph.D.Executive Officer
- Charles McOsker, Ph.D.Executive Officer
- Robert S. ReitmanDirector
- Terry VanceExecutive Officer
- Carmen Bozic, M.D.Director
- Ronald G. HarringtonDirector
- David C. U'Prichard, Ph.D.Director
- Jonathan S. Stamler, M.D.Director
- Stacie SwitzerExecutive Officer
- Graeme Martin, Ph.D.Director
- Offering amount
- $200M
- Amount sold
- $144.7M
- First sale
- Aug 2012
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through BioMotiv went on to found or lead other companies.
Frequently asked questions
- How much funding has BioMotiv raised?
- BioMotiv has disclosed $290.4M raised across 2 rounds.
- Where is BioMotiv headquartered?
- BioMotiv is headquartered in Cleveland, US.